The U.S. government has reached a deal with Moderna for 65 million additional COVID-19 vaccine doses, the Biden administration announced on July 29. The contract is valued at $1.7 billion.
Moderna will sell doses of its vaccine that target Omicron coronavirus subvariants, according to the agencies that announced the agreement. The actual contract hasn’t yet been made public.
